Surgery, Gastroenterology and Oncology
Vol. 30, No. 4-Supplement, Feb 2026
Age and its Impact in Breast Ductal Carcinoma In Situ: An Egyptian Tertiary Cancer Center Retrospective Experience
Ahmed Abdallah, Khaled Abdelwahab, Omar Hamdy, Shadi Awny, Mohammad Zuhdy, Khadiga M. Ali, Mona Zaky, Mohamed Amasha, Ahmed Ayman Eldesouky, Islam H. Metwally, Khalid Atallah
ORIGINAL PAPER, Feb 2026
Article DOI: 10.21614/sgo-812
Read article

Introduction: Ductal carcinoma in situ (DCIS) is rarely diagnosed in young female patients with most studies view age as a poor prognostic factor.

Patient and Methods: Female patients who underwent surgery for DCIS of the breast (with or without microinvasion) in our department between February 2007 and February 2022 were included. They were divided into two groups: group I (<40 years old) and group II (³40 years old), aiming to evaluate and compare the clinical-epidemiological, pathological, radiological, operative, and outcome data be....[more]

Investigation of RAD51 Gene Polymorphisms as Potential Biomarkers for Breast Cancer Susceptibility in Women
Ghasaq Abd Alkareem Nouri, Hassan Risan AlRikabi
ORIGINAL PAPER, Feb 2026
Article DOI: 10.21614/sgo-832
Read article

Background: Hereditary factors play a major role in breast cancer development, making it a serious global health concern for women. This study aimed to determine if RAD51 gene polymorphism rs1801320 (135 G>C) increases breast cancer risk in women in Thi-Qar Province, Iraq.

Methods: Forty women with breast cancer and twenty healthy volunteers participated. Data from blood samples were analyzed using Chi-square tests and odds ratios for PCR-based genotyping.

Results: The RAD51 gene variant rs1801320 did not show a....[more]

Bevacizumab-FOLFOXIRI in First Line Treatment of BRAF V600E - Mutant Metastatic Colorectal Cancer: A Single-Center Study
Asmaa Elkady, Sally Mashaal, Fatma Gharib
ORIGINAL PAPER, Feb 2026
Article DOI: 10.21614/sgo-858
Read article

Background: Treatment of metastatic colorectal cancer (mCRC) with BRAFV600E mutation is challenging. Resistance to treatment is a significant cause of unfavourable clinical outcomes. Aim: This work investigated the effectiveness and safety of bevacizumab (BEV) mFOLFOXIRI as an initial line of treatment of mCRC with BRAF V600E mutation.

Materials & Methods: This prospective, phase II, open-label study included 30 participants with mCRC harboring RAS wild-type and BRAF V600E mutation in primary tumors or metastases. Patients received 5 mg....[more]

Early Safety Profile of Merigrow Mesh in Elective Hernia Repair: A 12-Month Retrospective Analysis
Pushkar Galam, Nikil Jillawar, Panchhi Malve, Pavan P Goud, Kiran Kumar Shetty
ORIGINAL PAPER, Feb 2026
Article DOI: 10.21614/sgo-834
Read article

Background: Polypropylene meshes are widely used in hernia repair, with design and placement techniques significantly impacting postoperative outcomes. Merigrow™ Mesh is a microporous, lightweight polypropylene mesh that improves tissue integration while minimizing complications such as seroma, chronic pain and surgical site infections (SSI). This study evaluated its safety profile under real-world surgical conditions. Aim: To evaluate Merigrow™ Mesh safety and performance in elective hernia repair patients in a retrospective observational study.

more]

Overview of CNS Gliomas in the Kurdistan, Iraq
Shaiban Abdulsalam Almukhtar, Zahraa Jihad Hameedi, Mustafa Yasser Altamer, Anwar Sheikha, Hazha Abdullah Mohammed Ameen, Ahmed Alshewered
ORIGINAL PAPER, Feb 2026
Article DOI: 10.21614/sgo-811
Read article

Introduction: Globally, gliomas account for > 70% of all brain tumors. In Iraq, there is a tendency towards a higher rate of gliomas. The Iraqi Cancer Registry in 2019 stated that central nervous system tumors were among the top three cancers in Iraq and the top ten cancers in Sulaymaniyah.

Method: In this hospital-based frequency analysis study, information from 104 glioma patients was reviewed. Data were then subjected to critical analysis, taking into consideration all relevant factors related to demographic data (age, sex, and ethni....[more]

Role of Transient Elastography using Fibroscan in Predicting Hepatocellular Carcinoma in Liver Cirrhotic Patients
Enamol Hoque, Tapu Ghosh, Ummey Asma, Hasan Shahriar, Golam Mustafa
ORIGINAL PAPER, Feb 2026
Article DOI: 10.21614/sgo-855
Read article

Background: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third most common cause of cancer mortality. Underlying liver cirrhosis is the strongest predisposing factor for HCC. Many patients with HCC are diagnosed at an advanced stage when curative treatment is no longer feasible. Early detection of HCC is crucial for providing effective initial treatments. Fibroscan, a non-invasive, reproducible tool for assessing liver stiffness, may help identify patients with liver cirrhosis at high risk of developing HCC. Objective: To evalua....[more]

Amyand's Hernia - Dilemma for Appendicectomy
Nazreen Zakaria, Andee Dzulkarnaen Zakaria, Asri Che Jusoh
CASE REPORT, Feb 2026
Article DOI: 10.21614/sgo-809
Read article

Inguinal hernia is a common surgical condition worldwide and involves protrusion of an organ or its fascia through the abdominal wall. The hernia contents may include omentum, colon, small bowel, or its mesentery, while less common contents such as the appendix, ovary, or fallopian tube can also be present. Amyand’s hernia, in which the appendix is found within the sac, is one such rare form. We present a case of a 48-year-old male with a long-standing history of reducible right inguinal hernia who presented with acute onset right inguinal scrotal pain requiring emergency open r....[more]

Omental Infarct: Rare Diagnosis for Severe Right Sided Abdominal Pain
Anderson Cheong, James Lee
CASE REPORT, Feb 2026
Article DOI: 10.21614/sgo-848
Read article

A young gentleman presented with one day history of severe right sided abdominal pain with no other relevant history and normal blood work. Diagnostic laparoscopy revealed an omental infarct and resection was performed. He was well post operatively and discharged the following day.

BACKGROUND

Omental infarct is a rare cause of abdominal pain and usually has a similar presentation to appendicitis, cholecystitis, or diverticulitis. The first diagnosis of omental infarction was made by Bush in 1986 and since then, approximately 400 cases....[more]


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.